Drugs Used for Euthanasia: A Repeated Population-Based Mortality Follow-Back Study in Flanders, Belgium, 1998–2013
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 56 (4) , 551-559
Abstract
No abstract availableKeywords
Funding Information
- Flemish government Agency for Innovation by Science and Technology (100036)
This publication has 34 references indexed in Scilit:
- Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from 1990 to 2010: a repeated cross-sectional surveyThe Lancet, 2012
- Physician-assisted suicide: Ongoing challenges for pharmacistsAmerican Journal of Health-System Pharmacy, 2011
- Role and Involvement of Life End Information Forum Physicians in Euthanasia and Other End‐of‐Life Care Decisions in Flanders, BelgiumHealth Services Research, 2009
- Palliative sedation therapy does not hasten death: results from a prospective multicenter studyAnnals of Oncology, 2009
- The Reporting Rate of Euthanasia and Physician-Assisted SuicideMedical Care, 2008
- A post-mortem survey on end-of-life decisions using a representative sample of death certificates in Flanders, Belgium: research protocolBMC Public Health, 2008
- Having a difficult time leaving: experiences and attitudes of nurses with palliative sedationPalliative Medicine, 2007
- Changes in medical end-of-life practices during the legalization process of euthanasia in BelgiumSocial Science & Medicine, 2007
- Drugs used for euthanasia in Flanders, BelgiumPharmacoepidemiology and Drug Safety, 2003
- The Belgian Act on Euthanasia of May, 28th 2002Ethical Perspectives, 2002